Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative
Recommendations
As issued by the authors
Benefit-risk assessment of CV procedures should be based on well-defined neurological outcomes, ascertained with consistent methods, capturing the full spectrum of neurovascular injury and its clinical effect
Original publication
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Eur Heart J. Published 7 February 2017. doi:10.
Summarised from the published abstract; every number is checked against it